-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Downgrades Tenax Therapeutics to Neutral

Benzinga·08/31/2026 12:55:57
Listen to the news
Guggenheim analyst Seamus Fernandez downgrades Tenax Therapeutics (NASDAQ:TENX) from Buy to Neutral.